Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas

NCT00586508 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

DRUG: enzastaurin
DRUG: bevacizumab
DRUG: Enzyme-inducing antiepileptic drugs (EIAED)
DRUG: Non-enzyme inducing antiepileptic drugs (NEIAED)

Sponsor

Eli Lilly and Company

Collaborators

[object Object]